BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 789263)

  • 1. Macrophage function in leprosy.
    Parmaswaran M; Girdhar BK; Deo MG; Kandhari KC; Bhutani LK
    Int J Lepr Other Mycobact Dis; 1976; 44(3):340-5. PubMed ID: 789263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate of Mycobacterium leprae in macrophages of patients with lepromatous or tuberculoid leprosy.
    Godal T; Rees RJ
    Int J Lepr Other Mycobact Dis; 1970; 38(4):439-42. PubMed ID: 4929374
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF.
    Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Michel JC; Bach MA
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients.
    Robinson P; Mahadevan PR
    J Clin Lab Immunol; 1987 Dec; 24(4):171-6. PubMed ID: 3329228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolytic enzymes in macrophages from leprosy patients in presence of Mycobacterium leprae.
    Marolia J; Mahadevan PR
    Indian J Lepr; 1984; 56(4):776-83. PubMed ID: 6398340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
    Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical alteration in cells following phagocytosis of M. leprae--the consequence--a basic concept.
    Mahadevan PR; Antia NH
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):167-71. PubMed ID: 6995358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabelled M. leprae resident in human macrophage cultures as an in vitro indicator of effective immunity in human leprosy.
    Prasad HK; Singh R; Nath I
    Clin Exp Immunol; 1982 Sep; 49(3):517-22. PubMed ID: 6756718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of systemic and local activated macrophages in mice infected in the foot pad with Mycobacterium leprae and M. marinum.
    Krahenbuhl JL; Welch TM; Levy L
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):206-15. PubMed ID: 776858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage membrane alterations in leprosy as determined by change in sialic acid level.
    Agarwal S; Vemuri N; Mahadevan PR
    J Clin Lab Immunol; 1986 Mar; 19(3):119-22. PubMed ID: 3519974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
    Nath I; Van Rood JJ; Mehra NK; Vaidya MC
    Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
    Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic protein from Mycobacterium leprae released in macrophages in vitro as indicator of viability of bacteria.
    Nair I; Mahadevan PR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):540-7. PubMed ID: 2205688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
    Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy.
    Kaplan G; Nathan CF; Gandhi R; Horwitz MA; Levis WR; Cohn ZA
    J Immunol; 1986 Aug; 137(3):983-7. PubMed ID: 3088117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies.
    Narayanan RB; Ramu G; Sinha S; Sengupta U; Malaviya GN; Desikan KV
    Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.